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Time for a new approach to case reportsCase reports are popular and represent one of the oldest levels
of evidence. Despite this they have attracted much criticism. They
can be trivial, their conclusions do not usually undergo further
investigation, and they are often questioned as a poor excuse for
an unstructured review of the literature. Lessons from the past
have given strong warnings against using new drugs based solely
on case reports, such as the long-term adverse consequences of
fetal exposure to diethylstilboestrol (DES) in pregnancy.1 Case
reports are often not cited and hencemany journals routinely reject
them to protect their impact factors. Indeed, there is evidence that
the prevalence of these articles in high impact journals is in
decline.2
Many journals have reconsidered their policy towards case
reports over the years3,4 and there has been a recent vogue in
new journals publishing exclusively case reports,5–7 one of which
is no longer active.8 The International Journal of Surgery (IJS) has
had dissonance towards case reports since its launch in 2003.
Numbers steadily rose until they formed over a quarter of submis-
sions in 2007. Under the weight of these submissions we chose to
institute a policy of non-acceptance in late 2007, our instructions
to authors were updated and many enthusiastic authors were
rejected. Despite this, case reports have continued to be submitted
in large numbers. We tentatively started to accept case reports
again in mid-2009 with the bar set very high on quality and
novelty. We feel the time has now come for the ﬁrst dedicated
home for such articles – International Journal of Surgery: Case
Reports (IJSCR). The journal is due for launch on the 20 May 2010
and the IJS itself will no longer accept case reports from this point
forward. This editorial provides a synoptic exposition for this major
change in direction and its underlying rationale.
Clinicians – and surgeons in particular – learn from stories,
anecdotes and patient-based learning. Such learning has been
essential to the advance of healthcare.9 Clinical knowledge is
remembered far more efﬁciently when tagged to real-life events;
this is perhaps to be expected amongst human beings working in
such a highly organised social environment. Case reports can be
very sensitive at detecting novelty. By deﬁnition, the discovery of
every new condition, be it AIDS, SARS, Swine Flu or the next emer-
gent disease begins with a single case. They complement evidence-
based medicine, the learning of which should be drawn from
a broad range of sources. A recent study of drugs withdrawn from
the market found the scientiﬁc evidence for 19 out of 21 drugs
came from spontaneous case reports.10,11 Case reports were the
sole evidence in 12 and a randomized controlled trial (RCT) was
only responsible for one.12–15 Aronson16 and Glasziou et al.17 have1743-9191/$ – see front matter  2010 Surgical Associates Ltd. Published by Elsevier Lt
doi:10.1016/j.ijsu.2010.05.003described circumstances where case reports have provided deﬁni-
tive not just indicative evidence. Individual cases can also have
a major impact on health policy. In the UK, on 4 February 2010,
Coroner William Morris ruled the death of a 70-year-old patient
who was administered a tenfold overdose of diamorphine by
a German GP was an unlawful killing.18 This resulted in prompt
action by the UK Government to prevent similar cases.19
The relatively ‘open’ format of case reports for discussing atyp-
ical presentations, diagnostic challenges/pitfalls and rare condi-
tions is especially useful. Their less rigid structure allows the
surgeon(s) to discuss their diagnostic approach, the context, back-
ground, decision-making, reasoning and outcomes. Their human
perspective would be of unique and special value and provide
insights into the doctor–patient relationship. In addition, by
writing about their experiences, surgeons gain the opportunity to
reﬂect on their practice, an important aspect of personal develop-
ment often not afforded the time amongst busy clinics and theatre
lists. Yet we know their intrinsic value from patient safety inci-
dents, root cause analysis, morbidity and mortality meetings.
Case reports may remain the ‘lowest’ or ‘weakest’ level of
evidence with respect to causality but they remain the ﬁrst line
of evidence of what actually happened. They allow for the demon-
stration of novel surgical techniques (as laparoscopic cholecystec-
tomy was once upon a time) prior to more substantial
comparative analysis with established techniques such as RCTs.
The need for more case reports may have been paradoxically
increased by the drive for big RCTs. One of us (RA) has already
demonstrated some of the problems with surgical RCTs.20 People
with three or more chronic conditions account for around 80% of
healthcare activity; however, the evidence base that relates to
such people is poor. RCTs tend to exclude patients who have
more one than chronic condition in order to limit the number of
variables, potential confounding factors and to aid interpretation.
Yet how many of us deal with patients who may have diabetes,
arthritis, previous myocardial infarction, depression, chronic
obstructive airways disease, asthma and so on. This is not
uncommon, 40% of patients with long-term conditions have more
than one condition, and many have three or more.21 UK National
Institute for Health and Clinical Excellence (NICE) guidelines are
based on trials that deliberately excluded patients with comorbid-
ities. You just can’t do RCTs on every kind of patient but these are
the types of patients we see day in day out. The importance of
not forgetting outliers has been discussed elsewhere.22 Outliers in
larger studies are statistically sidelined and further analysis of
unexplained and unexpected observations is not conducted. It isd. All rights reserved.
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The other issue is generalisability. RCTs are often conducted in
centres of excellencewith the necessary funding, support and struc-
ture to make them happen. Their results may not be easily extrapo-
lated to low- and middle-income countries with limited resources.
RCT evidence on children, tropical diseases and surgical conditions
not found in the developed world is particularly poor.23 Searching
our database for patients in similar circumstances treated to the
best possible standards locally in the health service structure and
cost-base of that country would provide value and aid the deci-
sion-making process for both surgeon and patient. Such reports
stimulate learning and research and are capable of developing new
subject areas as well as providing excellent educational material to
students, trainees and lecturers. The addition ofmultimedia facilities
such as online video is of particular relevance to surgery – a craft
specialty.
In recent times, the ﬁrst face transplant24 and the ﬁrst uterine
transplant25 were presented as single cases. Despite the technical
successes and failures of such attempts at novel transplantations,
the reports themselves allowed the international scientiﬁc and
surgical community to gain useful insights at the ‘cutting edge’.
We learnt about the technical difﬁculties, immunological issues,
psychosocial and ethical dilemmas from the ‘front line’ so to speak.
It is with the richness of such cases and demand from authors that
we feel the time has come to launch IJSCR.
IJSCR will be online-only, peer reviewed and will only publish
case reports which are clinically interesting, original and educa-
tional. All published content will be universally available to
everyone on our dedicated website www.casereports.com and
the Science Direct platform (www.sciencedirect.com), which is
one of the world’s most advanced web delivery systems for
scientiﬁc, medical and technical content hosting more than 10
million articles with more than 11 million users. All published
content will be publicly posted on PubMedCentral (PMC) and our
aim is to ultimately achieve indexing in Medline as well. The
journal will also be indexed in SCOPUS, EMBASE and Google
Scholar soon after launch on May 10th. This business model of
freely accessible content will necessitate all authors paying an
article processing fee of £250 (plus VAT/Sales tax) should their
article be accepted for publication. This is in keeping with other
journals that operate such a business model26 and compares
favourably.
Types of cases we will be interested in include:
1. Reminder of an important clinical lesson.
2. ‘How I do it’.
3. Findings that shed new light on the possible pathogenesis of
a disease or an adverse effect.
4. Learning from errors.
5. Unusual presentation of more common disease/injury.
6. Myth exploded.
7. Rare disease.
8. New disease.
9. Novel diagnostic procedure.
10. Novel treatment (new drug/intervention, established drug/
procedure in new situation, use of new technology).
11. Unusual association of diseases/symptoms.
12. Unexpected outcome (positive or negative) including adverse
drug reactions.
Cases will be judged on clinical interest and educational value
not novelty or rarity. All authors should refer to our Guide to
Authors available online in the ﬁrst instance (http://ees.elsevier.
com/ijscasereports). We expect case reports to be short andsimple to prepare, thus providing an ideal way trainees to gain
writing and publishing experience.
This new journal in no way detracts from more rigorous studies
which the IJS will continue to publish and we wish to echo Sir Iain
Chalmers’ comments27 in response to the launch of another case
reports journal:
“In 1952, Austin Bradford Hill - the medical statisticianwho play
such an important part in introducing the randomized controlled
trial to medical research –’In my indictment of the statistician, I
would argue that he may tend to be a triﬂe too scornful of the clin-
ical judgments, the clinical impression. Such judgments are, I
believe, in essence, statistical. The clinician is attempting to make
a comparison between the situation that faces him at the moment
and a mentally recorded but otherwise untabulated past experi-
ence’. Twenty years later, Sam Shuster - a clinician - warned that
these impressions can be seriously misleading: ’There are lies,
damned lies, and clinical impressions’.28 Both Bradford Hill and
Shuster are right, of course: informal evaluation of care based on
impressions, and formal evaluation based on well-controlled
comparisons of alternative forms of care, both play essential roles
in the promotion of more effective care.”
We aim to develop the science of case reports and raise their
academic value. Ultimately, these case reports will form a rich data-
base, a corpus of clinical information which could be mined for
interesting trends/patterns, disease modelling and for the purposes
of surveillance (especially of rare diseases). Examples of such
collective value internationally include:
 The Global Trigger Tool from the Institute for Healthcare
Improvement (IHI) in the USA which has been shown to
increase the rate of adverse drug event detection approxi-
mately 50-fold over traditional reporting methodologies.29
 The Medicines and Healthcare products Regulatory Agency’s
(MHRA) YellowCard30 reporting system for adverse drug reac-
tions (ADRs).
 The National Patient Safety Agency (NPSA) in the UK, whose
National Learning and Reporting System31 (NLRS) relies on
single cases and where extraction of systemic lessons from
such data is now beginning to bear fruit.32
 The BEACH (Bettering the Evaluation And Care of Health) pro-
gramme in Australia has used 100 consecutive and randomly
sampled case reports each year from general practitioners to
describe ‘the characteristics of GPs and the patients who
consult them, patient reasons for encounter, the problems
managed and management techniques used’. The programme
now has over ten years of data and has been very important
in developing general practice in Australia.33
We hope that our database will be greater than the sum of its
parts too and the ‘wisdom of crowds’ will take it to new heights.34
This editorial represents an open call to the Sherlock Holmes within
us all and to the wider surgical community. Join us in this exciting
new venture and demonstrate the rich diversity of clinical surgery
by submitting your best cases to IJSCR at: http://ees.elsevier.com/
ijscasereports.Conﬂicts of interest
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